Ferring 
Welcome,         Profile    Billing    Logout  
 29 Products   56 Diseases   29 Products   154 Trials   7457 News 


«12...8485868788899091929394...9798»
  • ||||||||||  Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
    Trial primary completion date:  Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer (clinicaltrials.gov) -  Dec 4, 2015   
    P2,  N=100, Active, not recruiting, 
    Trial primary completion date: Dec 2018 --> Dec 2020 Trial primary completion date: Jul 2015 --> Dec 2015
  • ||||||||||  Orencia (abatacept) / BMS, Actemra IV (tocilizumab) / Roche, JW Pharma, Cimzia (certolizumab pegol) / Astellas, UCB
    Trial primary completion date:  Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity (clinicaltrials.gov) -  Dec 3, 2015   
    P4,  N=500, Recruiting, 
    Trial primary completion date: Jul 2015 --> Dec 2015 Trial primary completion date: Dec 2018 --> Dec 2020
  • ||||||||||  Cervidil (dinoprostone) / Ferring
    Trial completion:  CYTOPRO: Comparison Between 25  (clinicaltrials.gov) -  Nov 30, 2015   
    P2,  N=1700, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  Firmagon (degarelix) / Astellas, Ferring, Cetrotide (cetrorelix) / EMD Serono
    Enrollment open:  Dysregulation of FSH in Obesity: Functional and Statistical Analysis (clinicaltrials.gov) -  Nov 14, 2015   
    P=N/A,  N=68, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
  • ||||||||||  Firmagon (degarelix) / Astellas, Ferring
    Enrollment closed, Enrollment change, Metastases:  Effectiveness and Safety of Firmagon (clinicaltrials.gov) -  Oct 30, 2015   
    P=N/A,  N=103, Active, not recruiting, 
    Primary objectives could not be met due to critical missing information. Recruiting --> Active, not recruiting | N=200 --> 103
  • ||||||||||  Bravelle (urofollitropin) / Ferring
    Trial primary completion date:  Study of the Cleavage of the Egg in Relation to the Stimulation Treatment (clinicaltrials.gov) -  Oct 28, 2015   
    P=N/A,  N=600, Recruiting, 
    Recruiting --> Active, not recruiting | N=200 --> 103 Trial primary completion date: Mar 2016 --> Nov 2016
  • ||||||||||  Firmagon (degarelix) / Astellas, Ferring
    Trial primary completion date:  ProComD: Therapy Pathways in the Treatment of Hormone Na (clinicaltrials.gov) -  Oct 22, 2015   
    P=N/A,  N=1500, Recruiting, 
    Initiation date: Sep 2015 --> Dec 2016 | Trial primary completion date: Dec 2016 --> Mar 2018 Trial primary completion date: Dec 2018 --> Mar 2020
  • ||||||||||  Lutrelef (gonadorelin acetate) / Ferring
    Trial primary completion date:  LutrePulse Hypogonadotropic Hypogonadism (clinicaltrials.gov) -  Oct 22, 2015   
    P3,  N=60, Recruiting, 
    Trial primary completion date: Dec 2018 --> Mar 2020 Trial primary completion date: Apr 2016 --> Apr 2017
  • ||||||||||  Yervoy (ipilimumab) / BMS
    Trial primary completion date:  Ipilimumab + Androgen Depravation Therapy in Prostate Cancer (clinicaltrials.gov) -  Oct 22, 2015   
    P2,  N=48, Active, not recruiting, 
    Trial primary completion date: Apr 2016 --> Apr 2017 Trial primary completion date: Jun 2016 --> Jun 2017
  • ||||||||||  Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
    Enrollment open:  MEGASET HR: MENOPUR (clinicaltrials.gov) -  Oct 22, 2015   
    P4,  N=600, Recruiting, 
    Trial primary completion date: Jan 2016 --> Jan 2017 Not yet recruiting --> Recruiting
  • ||||||||||  Firmagon (degarelix) / Astellas, Ferring, T+AiTM (testosterone/anastrozole) / Havah Therapeutics
    Trial primary completion date:  Impact of Estradiol Addback (clinicaltrials.gov) -  Sep 24, 2015   
    P1,  N=60, Recruiting, 
    Trial primary completion date: Aug 2015 --> Feb 2016 Trial primary completion date: Jun 2016 --> Jun 2017
  • ||||||||||  Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
    New P4 trial:  MEGASET HR: MENOPUR (clinicaltrials.gov) -  Sep 18, 2015   
    P4,  N=600, Not yet recruiting,